Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
pmid:2600098
pmid:
Monti D et al. Influence of a Combination of Chemical Enhancers and Iontophoresis on In Vitro Transungual Permeation of Nystatin. 2018 AAPS PharmSciTech pmid:29484614
Llabot JM et al. Double-layered mucoadhesive tablets containing nystatin. 2002 AAPS PharmSciTech pmid:12916937
Rajendran K et al. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri. 2017 ACS Chem Neurosci pmid:29206032
Maroszyńska M et al. Antibiotics sensitivity of Candida clinical and food-borne isolates. 2013 Acta Biochim. Pol. pmid:24432323
Wu SC et al. Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway. 2018 Acta Biomater pmid:29128538
Martins HP et al. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. 2012 Acta Derm. Venereol. pmid:21918792
Aitken-Saavedra J et al. Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus. 2018 Acta Odontol. Scand. pmid:30045641
Ameye D et al. Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. 2005 Acta Otolaryngol. pmid:15966702
O'Grady MJ and Dempsey EM Antifungal prophylaxis for the prevention of neonatal candidiasis? 2008 Acta Paediatr. pmid:18363952
Bodenhoff J Development of strains of genus Candida and genus Torulopsis resistant to antimycotics. 1969 Acta Pathol Microbiol Scand pmid:4315885
Bodenhoff J Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B. 1968 Acta Pathol Microbiol Scand pmid:4301525
Lövgren T and Salmela I In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents. 1978 Acta Pathol Microbiol Scand B pmid:102108
Jørgensen F and Kroese AB Ionic selectivity of the mechano-electrical transduction channels in the hair cells of the frog sacculus. 1994 Acta Physiol. Scand. pmid:7914041
Ostlund E et al. Growth regulation of LLC-PK1 cells: lack of effect of Na(+)-loading. 1993 Acta Physiol. Scand. pmid:8392777
Sklenár Z et al. Compounded preparations with nystatin for oral and oromucosal administration. 2013 Jul-Aug Acta Pol Pharm pmid:23923400
Ocerin-Guerra I et al. Nystatin-induced acute generalized exanthematous pustulosis. 2012 Actas Dermosifiliogr pmid:23149047
Lollis TR and Bradshaw WT Fungal prophylaxis in neonates: a review article. 2014 Adv Neonatal Care pmid:24472884
Bodin MB et al. Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants. 2015 Adv Neonatal Care pmid:25938952
Woo KY et al. Peristomal skin complications and management. 2009 Adv Skin Wound Care pmid:20026934
Okechukwu DC et al. Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients. 2015 Afr Health Sci pmid:26957966
Moshi AH et al. Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension. 1998 AIDS pmid:9833873
Mukherjee PK et al. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. 2017 AIDS pmid:27677161
Selvam MP et al. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. 1993 AIDS Res. Hum. Retroviruses pmid:7686387
Goldenberg D et al. The use of otic powder in the treatment of acute external otitis. 2002 May-Jun Am J Otolaryngol pmid:12019482
Rao SP et al. Candida esophagitis in two children with acute leukemia: successful therapy with ketoconazole. 1985 Am J Pediatr Hematol Oncol pmid:3865555
Wolff LJ Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics. 1984 Am J Pediatr Hematol Oncol pmid:6393790
Berkowitz RJ et al. Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients. 1985 Am J Pediatr Hematol Oncol pmid:3898901
Violaris K et al. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. 2010 Am J Perinatol pmid:19504425
Sims ME et al. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. 1988 Am J Perinatol pmid:3276336
Manzoni P et al. Prevention of nosocomial infections in neonatal intensive care units. 2013 Am J Perinatol pmid:23292914
POLLACK B et al. AN ORAL SYNDROME COMPLICATING PSYCHOPHARMACOTHERAPY: STUDY II. 1964 Am J Psychiatry pmid:14211418
Mose S et al. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis? 1997 Am. J. Clin. Oncol. pmid:9256900
Turhan A et al. Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy. 1987 Am. J. Clin. Oncol. pmid:2441593
Zager RA Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content. 2000 Am. J. Kidney Dis. pmid:10922301
Lo WK et al. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. 1996 Am. J. Kidney Dis. pmid:8840945
Záruba K et al. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. 1991 Am. J. Kidney Dis. pmid:1986569
Meunier-Carpentier F Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections. 1984 Am. J. Med. pmid:6324589
Bow EJ et al. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients. 1984 Am. J. Med. pmid:6364804
Henry SA Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients. 1984 Am. J. Med. pmid:6369979
Bodey GP et al. Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission. 1979 Am. J. Med. pmid:84532
Gruenwald H et al. Philadelphia chromosome in eosinophilic leukemia. 1965 Am. J. Med. pmid:5853474
Winston DJ et al. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. 1986 Am. J. Med. pmid:3010716
Winston DJ et al. Prophylactic granulocyte transfusions during human bone marrow transplantation. 1980 Am. J. Med. pmid:6247910
Lee WM et al. Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function. 1986 Am. J. Med. Sci. pmid:3487248
Dan M Severe vulvovaginitis associated with intravaginal nystatin therapy. 2001 Am. J. Obstet. Gynecol. pmid:11483943
Proost JM et al. Miconazole in the treatment of mycotic vulvovaginitis. 1972 Am. J. Obstet. Gynecol. pmid:4551031
Van Slyke KK et al. Treatment of vulvovaginal candidiasis with boric acid powder. 1981 Am. J. Obstet. Gynecol. pmid:7282789
Diddle AW Trichomonas vaginalis: resistance to metronidazole. 1967 Am. J. Obstet. Gynecol. pmid:5182244